FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis
Ahead of its extended target action date of March 12, 2025, the FDA approved tapinarof cream 1% (Vtama; Organon) today for treating patients with atopic dermatitis (AD) aged 2 and older.1 Tapinarof cream 1% was previously approved in 2022 to treat adult …